Target Name: SIX5
NCBI ID: G147912
Review Report on SIX5 Target / Biomarker Content of Review Report on SIX5 Target / Biomarker
SIX5
Other Name(s): SIX homeobox 5 | Homeobox protein SIX5 | Sine oculis homeobox homolog 5 | sine oculis homeobox homolog 5 | SIX5_HUMAN | Dystrophia myotonica-associated homeodomain protein | DMAHP | BOR2 | dystrophia myotonica-associated homeodomain protein | DM locus-associated homeodomain protein

SIX5: A Potential Drug Target for Tissue Development and Maintenance

SIX5, also known as SIX500, is a protein that is expressed in a variety of tissues throughout the body. It is a key component of the homeobox gene family, which is a group of genes that are involved in the development and maintenance of various tissues and organs. SIX5 is one of the most well-studied members of this family, and a number of studies have identified it as a potential drug target or biomarker.

The homeobox genes are responsible for the development and maintenance of many different tissues and organs, including brain, heart, and blood vessels. These genes are expressed in a highly coordinated manner, with each gene producing a specific protein that is involved in the development and maintenance of its target tissue or organ. SIX5 is a member of the homeobox gene family, and it is expressed in a variety of tissues throughout the body, including the brain, heart, and blood vessels.

SIX5 is involved in the development and maintenance of the nervous system, including the brain. It is expressed in the brain and is involved in the formation of the nervous system, as well as the maintenance of the nervous system throughout life. SIX5 has been shown to play a role in the development of various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

In addition to its role in the nervous system, SIX5 is also involved in the development and maintenance of other tissues and organs. It is expressed in the heart and is involved in the formation of the heart, as well as the maintenance of the heart throughout life. SIX5 has also been shown to play a role in the development and maintenance of the blood vessels, including the brain blood vessels.

SIX5 is a potential drug target because of its involvement in the development and maintenance of various tissues and organs. Its expression in a variety of tissues and its role in the development and maintenance of these tissues make it an attractive target for drug developers. Additionally, its well-studied nature makes it easier for researchers to understand its function and identify potential drug targets.

In conclusion, SIX5 is a protein that is involved in the development and maintenance of various tissues and organs throughout the body. Its expression in a variety of tissues and its role in the development and maintenance of these tissues make it an attractive target for drug developers. Further research is needed to fully understand its function and identify potential drug targets.

Protein Name: SIX Homeobox 5

Functions: Transcription factor that is thought to be involved in regulation of organogenesis. May be involved in determination and maintenance of retina formation. Binds a 5'-GGTGTCAG-3' motif present in the ARE regulatory element of ATP1A1. Binds a 5'-TCA[AG][AG]TTNC-3' motif present in the MEF3 element in the myogenin promoter, and in the IGFBP5 promoter (By similarity). Thought to be regulated by association with Dach and Eya proteins, and seems to be coactivated by EYA1, EYA2 and EYA3 (By similarity)

The "SIX5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SIX5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SIX6 | SKA1 | SKA1 complex | SKA2 | SKA2P1 | SKA3 | SKAP1 | SKAP1-AS2 | SKAP2 | Skeletal muscle troponin | SKI | SKIC2 | SKIC3 | SKIC8 | SKIDA1 | SKIL | SKINT1L | SKOR1 | SKOR2 | SKP1 | SKP1P2 | SKP2 | SLA | SLA2 | SLAIN1 | SLAIN2 | SLAM Family Member | SLAMF1 | SLAMF6 | SLAMF6P1 | SLAMF7 | SLAMF8 | SLAMF9 | SLBP | SLC corepressor complex | SLC10A1 | SLC10A2 | SLC10A3 | SLC10A4 | SLC10A5 | SLC10A6 | SLC10A7 | SLC11A1 | SLC11A2 | SLC12A1 | SLC12A2 | SLC12A2-DT | SLC12A3 | SLC12A4 | SLC12A5 | SLC12A5-AS1 | SLC12A6 | SLC12A7 | SLC12A8 | SLC12A9 | SLC13A1 | SLC13A2 | SLC13A3 | SLC13A4 | SLC13A5 | SLC14A1 | SLC14A2 | SLC15A1 | SLC15A2 | SLC15A3 | SLC15A4 | SLC15A5 | SLC16A1 | SLC16A10 | SLC16A11 | SLC16A12 | SLC16A13 | SLC16A14 | SLC16A2 | SLC16A3 | SLC16A4 | SLC16A5 | SLC16A6 | SLC16A6P1 | SLC16A7 | SLC16A8 | SLC16A9 | SLC17A1 | SLC17A2 | SLC17A3 | SLC17A4 | SLC17A5 | SLC17A6 | SLC17A7 | SLC17A8 | SLC17A9 | SLC18A1 | SLC18A2 | SLC18A3 | SLC18B1 | SLC19A1 | SLC19A2 | SLC19A3 | SLC1A1 | SLC1A2